COVID-19 Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 107 pages | ID: C05FEEE47833EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of COVID-19 Drugs in Global, including the following market information:

Global COVID-19 Drugs Market Size 2023-2028, ($ millions)

The global COVID-19 Drugs market is projected to reach US$ million by 2028.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COVID-19 Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COVID-19 Drugs Market, by Type, 2023-2028 ($ millions)

Global COVID-19 Drugs Market Segment Percentages, by Type

• Tablet
• Injection

Global COVID-19 Drugs Market, by Application, 2023-2028 ($ millions)

Global COVID-19 Drugs Market Segment Percentages, by Application

• Mild Symptom Patient
• Critically Ill Patient

Global COVID-19 Drugs Market, By Region and Country, 2023-2028 ($ Millions)

Global COVID-19 Drugs Market Segment Percentages, By Region and Country

• United States
• Europe
• Asia
• China
• Rest of World

Competitor Analysis

The report also provides analysis of leading market participants including:

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Novartis
• Shanghai Zhongxisanwei
• Teva
• Zydus Cadila
• Mylan
• Apotex
• Advanz Pharma
• Sun Pharma
• Kyung Poong
• Ipca Laboratories
• Hanlim Pharmaceutical
• Bristol Laboratories
• Bayer
• Rising Pharmaceutical
• Shanghai Pharma
• Sichuan Sunny Hope
• Guangzhou Baiyunshan Guanghua Pharmaceutical
• CSPC Group
• KPC Group
• Jinghua Pharmaceutical Group
• Zhongsheng Pharma
• North China Pharmaceutical Group

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 COVID-19 Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global COVID-19 Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COVID-19 DRUGS OVERALL MARKET SIZE

2.1 Global COVID-19 Drugs Market Size: 2022 VS 2028
2.2 Global COVID-19 Drugs Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Key COVID-19 Drugs Players in Global Market
3.2 Global Companies COVID-19 Drugs Product & Technology

4 PLAYERS PROFILES

4.1 Sanofi
  4.1.1 Sanofi Corporate Summary
  4.1.2 Sanofi Business Overview
  4.1.3 Sanofi COVID-19 Drugs Product Offerings & Technology
  4.1.4 Sanofi COVID-19 Drugs R&D, and Plans
4.2 Novartis
  4.2.1 Novartis Corporate Summary
  4.2.2 Novartis Business Overview
  4.2.3 Novartis COVID-19 Drugs Product Offerings & Technology
  4.2.4 Novartis COVID-19 Drugs R&D, and Plans
4.3 Shanghai Zhongxisanwei
  4.3.1 Shanghai Zhongxisanwei Corporate Summary
  4.3.2 Shanghai Zhongxisanwei Business Overview
  4.3.3 Shanghai Zhongxisanwei COVID-19 Drugs Product Offerings & Technology
  4.3.4 Shanghai Zhongxisanwei COVID-19 Drugs R&D, and Plans
4.4 Teva
  4.4.1 Teva Corporate Summary
  4.4.2 Teva Business Overview
  4.4.3 Teva COVID-19 Drugs Product Offerings & Technology
  4.4.4 Teva COVID-19 Drugs R&D, and Plans
4.5 Zydus Cadila
  4.5.1 Zydus Cadila Corporate Summary
  4.5.2 Zydus Cadila Business Overview
  4.5.3 Zydus Cadila COVID-19 Drugs Product Offerings & Technology
  4.5.4 Zydus Cadila COVID-19 Drugs R&D, and Plans
4.6 Mylan
  4.6.1 Mylan Corporate Summary
  4.6.2 Mylan Business Overview
  4.6.3 Mylan COVID-19 Drugs Product Offerings & Technology
  4.6.4 Mylan COVID-19 Drugs R&D, and Plans
4.7 Apotex
  4.7.1 Apotex Corporate Summary
  4.7.2 Apotex Business Overview
  4.7.3 Apotex COVID-19 Drugs Product Offerings & Technology
  4.7.4 Apotex COVID-19 Drugs R&D, and Plans
4.8 Advanz Pharma
  4.8.1 Advanz Pharma Corporate Summary
  4.8.2 Advanz Pharma Business Overview
  4.8.3 Advanz Pharma COVID-19 Drugs Product Offerings & Technology
  4.8.4 Advanz Pharma COVID-19 Drugs R&D, and Plans
4.9 Sun Pharma
  4.9.1 Sun Pharma Corporate Summary
  4.9.2 Sun Pharma Business Overview
  4.9.3 Sun Pharma COVID-19 Drugs Product Offerings & Technology
  4.9.4 Sun Pharma COVID-19 Drugs R&D, and Plans
4.10 Kyung Poong
  4.10.1 Kyung Poong Corporate Summary
  4.10.2 Kyung Poong Business Overview
  4.10.3 Kyung Poong COVID-19 Drugs Product Offerings & Technology
  4.10.4 Kyung Poong COVID-19 Drugs R&D, and Plans
4.11 Ipca Laboratories
  4.11.1 Ipca Laboratories Corporate Summary
  4.11.2 Ipca Laboratories Business Overview
  4.11.3 Ipca Laboratories COVID-19 Drugs Product Offerings & Technology
  4.11.4 Ipca Laboratories COVID-19 Drugs R&D, and Plans
4.12 Hanlim Pharmaceutical
  4.12.1 Hanlim Pharmaceutical Corporate Summary
  4.12.2 Hanlim Pharmaceutical Business Overview
  4.12.3 Hanlim Pharmaceutical COVID-19 Drugs Product Offerings & Technology
  4.12.4 Hanlim Pharmaceutical COVID-19 Drugs R&D, and Plans
4.13 Bristol Laboratories
  4.13.1 Bristol Laboratories Corporate Summary
  4.13.2 Bristol Laboratories Business Overview
  4.13.3 Bristol Laboratories COVID-19 Drugs Product Offerings & Technology
  4.13.4 Bristol Laboratories COVID-19 Drugs R&D, and Plans
4.14 Bayer
  4.14.1 Bayer Corporate Summary
  4.14.2 Bayer Business Overview
  4.14.3 Bayer COVID-19 Drugs Product Offerings & Technology
  4.14.4 Bayer COVID-19 Drugs R&D, and Plans
4.15 Rising Pharmaceutical
  4.15.1 Rising Pharmaceutical Corporate Summary
  4.15.2 Rising Pharmaceutical Business Overview
  4.15.3 Rising Pharmaceutical COVID-19 Drugs Product Offerings & Technology
  4.15.4 Rising Pharmaceutical COVID-19 Drugs R&D, and Plans
4.16 Shanghai Pharma
  4.16.1 Shanghai Pharma Corporate Summary
  4.16.2 Shanghai Pharma Business Overview
  4.16.3 Shanghai Pharma COVID-19 Drugs Product Offerings & Technology
  4.16.4 Shanghai Pharma COVID-19 Drugs R&D, and Plans
4.17 Sichuan Sunny Hope
  4.17.1 Sichuan Sunny Hope Corporate Summary
  4.17.2 Sichuan Sunny Hope Business Overview
  4.17.3 Sichuan Sunny Hope COVID-19 Drugs Product Offerings & Technology
  4.17.4 Sichuan Sunny Hope COVID-19 Drugs R&D, and Plans
4.18 Guangzhou Baiyunshan Guanghua Pharmaceutical
  4.18.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Corporate Summary
  4.18.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
  4.18.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product Offerings & Technology
  4.18.4 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs R&D, and Plans
4.19 CSPC Group
  4.19.1 CSPC Group Corporate Summary
  4.19.2 CSPC Group Business Overview
  4.19.3 CSPC Group COVID-19 Drugs Product Offerings & Technology
  4.19.4 CSPC Group COVID-19 Drugs R&D, and Plans
4.20 KPC Group
  4.20.1 KPC Group Corporate Summary
  4.20.2 KPC Group Business Overview
  4.20.3 KPC Group COVID-19 Drugs Product Offerings & Technology
  4.20.4 KPC Group COVID-19 Drugs R&D, and Plans
4.21 Jinghua Pharmaceutical Group
  4.21.1 Jinghua Pharmaceutical Group Corporate Summary
  4.21.2 Jinghua Pharmaceutical Group Business Overview
  4.21.3 Jinghua Pharmaceutical Group COVID-19 Drugs Product Offerings & Technology
  4.21.4 Jinghua Pharmaceutical Group COVID-19 Drugs R&D, and Plans
4.22 Zhongsheng Pharma
  4.22.1 Zhongsheng Pharma Corporate Summary
  4.22.2 Zhongsheng Pharma Business Overview
  4.22.3 Zhongsheng Pharma COVID-19 Drugs Product Offerings & Technology
  4.22.4 Zhongsheng Pharma COVID-19 Drugs R&D, and Plans
4.23 North China Pharmaceutical Group
  4.23.1 North China Pharmaceutical Group Corporate Summary
  4.23.2 North China Pharmaceutical Group Business Overview
  4.23.3 North China Pharmaceutical Group COVID-19 Drugs Product Offerings & Technology
  4.23.4 North China Pharmaceutical Group COVID-19 Drugs R&D, and Plans

5 SIGHTS BY REGION

5.1 By Region - Global COVID-19 Drugs Market Size, 2023 & 2028
5.2 By Region - Global COVID-19 Drugs Revenue, (2023-2028)
5.3 United States
  5.3.1 Key Players of COVID-19 Drugs in United States
  5.3.2 United States COVID-19 Drugs Development Current Situation and Forecast
5.4 Europe
  5.4.1 Key Players of COVID-19 Drugs in Europe
  5.4.2 Europe COVID-19 Drugs Development Current Situation and Forecast
5.5 China
  5.5.1 Key Players of COVID-19 Drugs in China
  5.5.2 China COVID-19 Drugs Development Current Situation and Forecast
5.6 Rest of World

6 SIGHTS BY PRODUCT

6.1 by Type - Global COVID-19 Drugs Market Size Markets, 2023 & 2028
6.2 Tablet
6.3 Injection

7 SIGHTS BY APPLICATION

7.1 By Application - Global COVID-19 Drugs Market Size, 2023 & 2028
7.2 Mild Symptom Patient
7.3 Critically Ill Patient

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. COVID-19 Drugs Market Opportunities & Trends in Global Market
Table 2. COVID-19 Drugs Market Drivers in Global Market
Table 3. COVID-19 Drugs Market Restraints in Global Market
Table 4. Key Players of COVID-19 Drugs in Global Market
Table 5. Global Companies COVID-19 Drugs Product & Technology
Table 6. Sanofi Corporate Summary
Table 7. Sanofi COVID-19 Drugs Product Offerings
Table 8. Novartis Corporate Summary
Table 9. Novartis COVID-19 Drugs Product Offerings
Table 10. Shanghai Zhongxisanwei Corporate Summary
Table 11. Shanghai Zhongxisanwei COVID-19 Drugs Product Offerings
Table 12. Teva Corporate Summary
Table 13. Teva COVID-19 Drugs Product Offerings
Table 14. Zydus Cadila Corporate Summary
Table 15. Zydus Cadila COVID-19 Drugs Product Offerings
Table 16. Mylan Corporate Summary
Table 17. Mylan COVID-19 Drugs Product Offerings
Table 18. Apotex Corporate Summary
Table 19. Apotex COVID-19 Drugs Product Offerings
Table 20. Advanz Pharma Corporate Summary
Table 21. Advanz Pharma COVID-19 Drugs Product Offerings
Table 22. Sun Pharma Corporate Summary
Table 23. Sun Pharma COVID-19 Drugs Product Offerings
Table 24. Kyung Poong Corporate Summary
Table 25. Kyung Poong COVID-19 Drugs Product Offerings
Table 26. Ipca Laboratories Corporate Summary
Table 27. Ipca Laboratories COVID-19 Drugs Product Offerings
Table 28. Hanlim Pharmaceutical Corporate Summary
Table 29. Hanlim Pharmaceutical COVID-19 Drugs Product Offerings
Table 30. Bristol Laboratories Corporate Summary
Table 31. Bristol Laboratories COVID-19 Drugs Product Offerings
Table 32. Bayer Corporate Summary
Table 33. Bayer COVID-19 Drugs Product Offerings
Table 34. Rising Pharmaceutical Corporate Summary
Table 35. Rising Pharmaceutical COVID-19 Drugs Product Offerings
Table 36. Shanghai Pharma Corporate Summary
Table 37. Shanghai Pharma COVID-19 Drugs Product Offerings
Table 38. Sichuan Sunny Hope Corporate Summary
Table 39. Sichuan Sunny Hope COVID-19 Drugs Product Offerings
Table 40. Guangzhou Baiyunshan Guanghua Pharmaceutical Corporate Summary
Table 41. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product Offerings
Table 42. CSPC Group Corporate Summary
Table 43. CSPC Group COVID-19 Drugs Product Offerings
Table 44. KPC Group Corporate Summary
Table 45. KPC Group COVID-19 Drugs Product Offerings
Table 46. Jinghua Pharmaceutical Group Corporate Summary
Table 47. Jinghua Pharmaceutical Group COVID-19 Drugs Product Offerings
Table 48. Zhongsheng Pharma Corporate Summary
Table 49. Zhongsheng Pharma COVID-19 Drugs Product Offerings
Table 50. North China Pharmaceutical Group Corporate Summary
Table 51. North China Pharmaceutical Group COVID-19 Drugs Product Offerings
Table 52. By Region– Global COVID-19 Drugs Revenue, (US$, Mn), 2023 & 2028
Table 53. By Region - Global COVID-19 Drugs Revenue, (US$, Mn), 2023-2028
Table 54. By Type – Global COVID-19 Drugs Market Size, (US$, Mn), 2023 & 2028
Table 55. By Application– Global COVID-19 Drugs Market Size, (US$, Mn), 2023 & 2028

List Of Figures

LIST OF FIGURES

Figure 1. COVID-19 Drugs Segment by Type in 2021
Figure 2. COVID-19 Drugs Segment by Application in 2021
Figure 3. Global COVID-19 Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 Drugs Market Size: 2022 VS 2028 (US$, Mn)
Figure 6. Global COVID-19 Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 Drugs Revenue Market Share, 2023-2028
Figure 8. By Type - Global COVID-19 Drugs Revenue Market Share, 2023-2028
Figure 9. By Application - Global COVID-19 Drugs Revenue Market Share, 2023-2028